Mark J. Ratain to Oligonucleotides, Antisense
This is a "connection" page, showing publications Mark J. Ratain has written about Oligonucleotides, Antisense.
Connection Strength
0.513
-
A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors. Ann Oncol. 2005 Jun; 16(6):958-65.
Score: 0.260
-
Delivery of a liposomal c-raf-1 antisense oligonucleotide by weekly bolus dosing in patients with advanced solid tumors: a phase I study. Clin Cancer Res. 2004 Nov 01; 10(21):7244-51.
Score: 0.252